Jefferies Financial Group’s AbbVie ABBV Stock Holding History

Jefferies Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,000	Closed	-$711K	–	1565
2024 Q4	$711K	Buy	+4,000	New	+$735K	﹤0.01%	1000
2023 Q3	–	Sell	-65,500	Closed	-$8.82M	–	1573
2023 Q2	$8.82M	Buy	65,500 +4,400	+7%	+$645K	0.08%	234
2023 Q1	$9.74M	Sell	61,100 -59,500	-49%	-$9.1M	0.08%	216
2022 Q4	$19.5M	Buy	+120,600	New	+$18.5M	0.14%	124

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jefferies Financial Group's ABBV Position: Q2 2026 in Review

Jefferies Financial Group increased its AbbVie (ABBV) stake by 29% in Q2 2026, buying an estimated $12.9M and bringing the position to 268,264 shares worth $67.5M. The position accounts for 0.44% of the portfolio, ranked #33.

Jefferies Financial Group first reported a position in ABBV in Q1 2017 and has held it in 20 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Jefferies Financial Group held 268,264 shares of AbbVie worth $67.5M as of Q2 2026.
Jefferies Financial Group bought 59,905 AbbVie shares in Q2 2026, an estimated $12.9M.
AbbVie made up 0.44% of Jefferies Financial Group's portfolio in Q2 2026, its #33 holding.
Jefferies Financial Group first reported a position in AbbVie in Q1 2017 and has held it in 20 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.